1. Home
  2. ANGI vs ORGO Comparison

ANGI vs ORGO Comparison

Compare ANGI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANGI
  • ORGO
  • Stock Information
  • Founded
  • ANGI 1995
  • ORGO 1985
  • Country
  • ANGI United States
  • ORGO United States
  • Employees
  • ANGI N/A
  • ORGO N/A
  • Industry
  • ANGI Advertising
  • ORGO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANGI Consumer Discretionary
  • ORGO Health Care
  • Exchange
  • ANGI Nasdaq
  • ORGO Nasdaq
  • Market Cap
  • ANGI 566.2M
  • ORGO 533.9M
  • IPO Year
  • ANGI 2017
  • ORGO N/A
  • Fundamental
  • Price
  • ANGI $15.78
  • ORGO $2.69
  • Analyst Decision
  • ANGI Buy
  • ORGO Buy
  • Analyst Count
  • ANGI 8
  • ORGO 2
  • Target Price
  • ANGI $21.36
  • ORGO $5.50
  • AVG Volume (30 Days)
  • ANGI 1.5M
  • ORGO 1.7M
  • Earning Date
  • ANGI 05-06-2025
  • ORGO 05-08-2025
  • Dividend Yield
  • ANGI N/A
  • ORGO N/A
  • EPS Growth
  • ANGI N/A
  • ORGO N/A
  • EPS
  • ANGI 1.03
  • ORGO N/A
  • Revenue
  • ANGI $1,125,635,000.00
  • ORGO $458,760,000.00
  • Revenue This Year
  • ANGI N/A
  • ORGO $2.73
  • Revenue Next Year
  • ANGI $3.69
  • ORGO $12.28
  • P/E Ratio
  • ANGI $15.17
  • ORGO N/A
  • Revenue Growth
  • ANGI N/A
  • ORGO 5.35
  • 52 Week Low
  • ANGI $10.88
  • ORGO $2.28
  • 52 Week High
  • ANGI $29.15
  • ORGO $6.71
  • Technical
  • Relative Strength Index (RSI)
  • ANGI 56.13
  • ORGO 30.20
  • Support Level
  • ANGI $15.46
  • ORGO $2.96
  • Resistance Level
  • ANGI $16.45
  • ORGO $3.28
  • Average True Range (ATR)
  • ANGI 0.58
  • ORGO 0.16
  • MACD
  • ANGI -0.07
  • ORGO -0.04
  • Stochastic Oscillator
  • ANGI 17.18
  • ORGO 2.65

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: